Evidence map›Paper›PMID 16269547›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds.

Todd A Sulchek, Raymond W Friddle, Kevin Langry, Edmond Y Lau, Huguette Albrecht, Timothy V Ratto, Sally J DeNardo, Michael E Colvin, Aleksandr Noy

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Single-Molecule Force Spectroscopy: Experiments, Analysis, and Simulations.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Theory for nonlinear dynamic force spectroscopy.European biophysics journal : EBJ · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Todd A SulchekLawrence Livermore National Laboratory, Livermore, CA 94550, USA.
Raymond W Friddle
Kevin Langry
Edmond Y Lau
Huguette Albrecht
Timothy V Ratto
Sally J DeNardo
Michael E Colvin
Aleksandr Noy

Funding

TREATMENT OF B CELL MALIGNANCIES.P01CA047829 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI DENARDO, GERALD L · 1988 to 2006
$10.0M
NCI NIH HHS CA47829NCI NIH HHS P01 CA047829
6 · The paper itself

Abstract

We used atomic force microscopy to measure the binding forces between Mucin1 (MUC1) peptide and a single-chain variable fragment (scFv) antibody selected from a scFv library screened against MUC1. This binding interaction is central to the design of molecules used for targeted delivery of radioimmunotherapeutic agents for prostate and breast cancer treatment. Our experiments separated the specific binding interaction from nonspecific interactions by tethering the antibody and MUC1 molecules to the atomic force microscope tip and sample surface with flexible polymer spacers. Rupture force magnitude and elastic characteristics of the spacers allowed identification of the rupture events corresponding to different numbers of interacting proteins. We used dynamic force spectroscopy to estimate the intermolecular potential widths and equivalent thermodynamic off rates for monovalent, bivalent, and trivalent interactions. Measured interaction potential parameters agree with the results of molecular docking simulation. Our results demonstrate that an increase of the interaction valency leads to a precipitous decline in the dissociation rate. Binding forces measured for monovalent and multivalent interactions match the predictions of a Markovian model for the strength of multiple uncorrelated bonds in a parallel configuration. Our approach is promising for comparison of the specific effects of molecular modifications as well as for determination of the best configuration of antibody-based multivalent targeting agents.

Indexed as

Amino Acid SequenceAntibodiesImmunoglobulin FragmentsMicroscopy, Atomic ForceModels, MolecularMolecular Sequence DataMucinsSpectrum AnalysisAntibodiesImmunoglobulin FragmentsMucins

Identifiers

PMID16269547
PMCPMC1276867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.